Consensus CARGO Therapeutics, Inc.

Equities

CRGX

US14179K1016

Market Closed - Nasdaq Other stock markets 21:00:00 18/06/2024 BST			5-day change	1st Jan Change
15.43 ^USD	-3.08%		-11.42%	-33.35%

06-04	CARGO Therapeutics, Inc. Announces the Appointment of Jane Pritchett Henderson as Independent Director	CI
05-28	CARGO Therapeutics, Inc. announced that it expects to receive $110.007 million in funding	CI

Evolution of the average Target Price on CARGO Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

832677736002f794327c6ff7a87.untUQ8xDAr1SWNSR5g18F59_R74Y5-tAwQ35fGczgN4.6jcCE6kWTfoDC5LUjX8uT_AzDfV9uNkhp0erFhZG1O7eCjc0mCRW6yo7nQ~ebddb389de4c07c2fb07d2a9a1f56e26

Analyst Recommendations on CARGO Therapeutics, Inc.

Truist Securities Cuts Price Target on CARGO Therapeutics to $32 From $34, Maintains Buy Rating	05-15	MT
TD Cowen Initiates Coverage on CARGO Therapeutics With Outperform Rating	12-05	MT
Truist Securities Initiates Coverage on CARGO Therapeutics With Buy Rating, $34 Price Target	12-05	MT
Jefferies Initiates Cargo Therapeutics at Buy Rating With $28 Price Target	12-05	MT
JPMorgan Initiates Cargo Therapeutics at Overweight Rating With $23 Price Target	12-05	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

15.43 USD

Average target price

31.33 USD

Spread / Average Target

+103.07%

High Price Target

32 USD

Spread / Highest target

+107.39%

Low Price Target

30 USD

Spread / Lowest Target

+94.43%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CARGO Therapeutics, Inc.

Truist Securities
JPMorgan Chase
Jefferies & Co.
TD Cowen

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar